NVE Corporation

Company: NVE Corporation
Ticker: NVEC

Submit Your Information

If you suffered a loss on your NVE Corporation investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below. Please note that submission of this form does not by itself form an attorney-client relationship nor does filling out this form mean you have joined any lawsuit.

First Name*

Last Name*

Email*

Phone*

City

State

Country

Total # of shares

First Purchase Date

Last Purchase Date

Estimated Loss Range

Check here if you still hold any shares.

Check here if you are a current or former employee of the company.

Check here if you purchased any shares before

Additional Comments

Background

On October 21, 2026, NVE Corporation reported its financial results for the second quarter of fiscal 2027, revealing, among other things, that quarter over quarter revenue decreased 47%, product sales decreased 48%, gross profit decreased 49%, and diluted EPS decreased 51%.

During the Company’s earnings call, Principal Financial Officer Daniel Nelson stated that “[t]he decrease in product sales was due to a short-term inventory adjustment at one of our large medical device customers and a 95% decrease in defense product sales.” Nelson stated that “we expect revenues in the second half of the fiscal year to be consistent with the first half.” The Company’s CEO, Peter Eames, further revealed the “variability was primarily from orders being pulled into quarter 1 from quarter 2.”

On this news, NVE stock fell as much as $31.56, or 30.62%, during intraday trading on October 22, 2026, thereby injuring investors.

Submit Your Information